surmount-1 trial tirzepatide weight loss results shows 47% greater vs. Wegovy Tirzepatide Was Associated with Improved
Description
Studies show that GI side effects in tirzepatide trials were predominantly mild to moderate and concentrated during the dose escalation period
The Takeaway Meno belly is the result of an increase in abdominal fat that often seems to come out of nowhere during perimenopause and menopause due to both a redistribution of fat and weight gain
Some patients may not reach their optimal therapeutic dose if titration is delayed or stopped prematurely due to side effects
Appetite pattern: Note when you feel hungriest and when appetite suppression is strongest
Poor sleep quality disrupts leptin and ghrelin regulation
